Vascular Neurology

Latest News

Ophthalmologists Vital in Mitigating Systemic Risks for Patients With Diabetic Retinopathy

Higher degrees of diabetic retinopathy also carry risk for cardiovascular events, the study shows.

Rivaroxaban vs Standard Anticoagulants for Pediatric Cerebral Venous Thrombosis

Among pediatric patients with cerebral venous thrombosis, treatment with rivaroxaban or standard anticoagulants resulted in a similarly reduced risk for recurrent VTE or bleeding.

Asymptomatic Brain Bleeds in Newborns Not Tied to Long-Term Harm

Neurodevelopmental scores and gray matter volumes at age 2 years do not differ between asymptomatic neonates with SDH and control neonates.

Higher Creatinine Predicts AKI in Intracerebral Hemorrhage Cases

In a study of patients with intracerebral hemorrhage, those with baseline creatinine levels of 110 µmol/L or higher and who received higher doses of nicardipine, a hypertensive drug, had an increased risk for acute kidney injury.

Study Suggests Smoking Causes Fatal Subarachnoid Hemorrhage

Smoking seems to have a causal role in subarachnoid hemorrhage death compared with nonsmoking.

Systolic Blood Pressure and Orthostatic Hypotension Are Linked to Dementia

Systolic orthostatic hypotension and variability in systolic blood pressure postural changes may be associated with increased dementia risk.

Black Patients Have Higher Incidence of Cerebral Venous Thrombosis

Black Americans have a higher incidence of cerebral venous thrombosis (CVT) compared with other races.

Mental Stress-Induced Brain Activation Linked to Angina

Mental stress-induced inferior frontal lobe activation is associated with angina among patients with coronary artery disease.

Medical Management Alone Better for Brain AV Malformations

Among patients with unruptured brain arteriovenous malformation, medical management alone is superior to its combination with interventional therapy for prevention of death or symptomatic stroke in the long term.

DOAC Plus Antiplatelet Redued Embolic Event Risk After Carotid Artery Stenting

Administration of DOAC in combination with an antiplatelet agent may reduce the risk for hemorrhagic and embolic events in patients with nonvalvular atrial fibrillation following carotid artery stenting.